Vetoquinol - Universal Registration Document - 2021

1 14 Vetoquinol Universal Registration Document 2020 Financial report PRESENTATION OF THE GROUP Value-creating business model RESSOURCES www.vetoquinol.com Our vision To be themost flexible animal health laboratory, where stakeholders work together to create customized solutions for a better planet. INNOVATE 6 targeted therapeutic domains: TEMR ERH MRƽEQQEXMSR HIVQEXSPSK] TEVEWMXSPSK] VIWTMVEXSV] HMWIEWIW YHHIV LIEPXL ERH VITVSHYGXMSR > 100 TEVXRIVW YRMZIVWMXMIW PEFSVEXSVMIW &MSXIGLW Vetoquinol is a key player in the global animal health market, which is estimated at $35 billion, with annual growth of 3% to 5%. A family-owned laboratory with an international presence and nearly 90 years focused solely on animal health TRANSFORM (IZIPST LYQER GETMXEP 'SRXMRYSYW MRHYWXVMEP MQTVSZIQIRX Customer experience )RZMVSRQIRXEP ETTVSEGL * Europe, UK and Australia. ** Europe, UK, Australia and Canada. *** Before depreciation of acquired assets. HUMAN 2,400 IQTPS]IIW TVIWIRX in 24 countries FINANCIAL €371m MR WLEVILSPHIVWƅ IUYMX] €4m in net cash after ETTP]MRK -*67 R&D 6 6 ( GIRXIVW 7% SJ WEPIW MRZIWXIH MR 6 ( 180 6 ( VIWIEVGLIVW INDUSTRIAL 6 production sites €57m MR TYVGLEWIW SJ VE[ QEXIVMEPW and packaging items ENVIRONMENTAL )RIVK] ERH [EXIV SOCIAL 6IPEXMSRWLMTW [MXL SYV WXEOILSPHIVW *EQMP] S[RIVWLMT WXVYGXYVI SHAREHOLDERS 67% )XMIRRI *VIGLMR JEQMP] and 33% ƽSEX SUPPLIERS 2,300 WYTTPMIVW ERH TEVXRIVW 1.4 Value-creating business model